Loading...
XSWXDOCM
Market cap305mUSD
Dec 23, Last price  
20.04CHF
1D
1.37%
1Q
-39.67%
IPO
-86.64%
Name

Zur Rose Group AG

Chart & Performance

D1W1MN
XSWX:DOCM chart
P/E
3.34
P/S
0.28
EPS
6.01
Div Yield, %
0.00%
Shrs. gr., 5y
12.95%
Rev. gr., 5y
-4.29%
Revenues
969m
-39.72%
488,269,000487,192,000523,306,000910,609,000915,554,000834,418,000879,535,000982,921,0001,207,108,0001,355,539,0001,476,930,0001,726,503,0001,608,222,000969,462,000
Net income
82m
P
3,921,0008,674,0006,156,000-15,464,0007,154,0003,445,000-12,769,000-36,238,000-38,971,000-52,358,000-135,695,000-225,735,000-171,115,00082,280,000
CFO
-87m
L-10.15%
13,960,0002,806,00020,809,0002,004,0007,200,00018,872,000-13,830,000-22,227,000-33,227,000-82,571,000-67,511,000-130,631,000-97,287,000-87,415,000
Earnings
Mar 19, 2025

Profile

DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. The company offers prescription and over-the-counter medicines, consumer health products, beauty and personal care products, nutritional supplements, painkillers, and first aid products, as well as medicines management services. It also operates stationary pharmacy shops. The company sells its products directly to physicians, online mail-order pharmacies, and private individuals under the Zur Rose, PromoFarma, TeleClinic, and DocMorris brands. The company was formerly known as Zur Rose Group AG and changed its name to DocMorris AG in May 2023. DocMorris AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.
URL
https://www.zurrosegroup.com/
IPO date
Jul 06, 2017
Employees
2,283
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
969,462
-39.72%
1,608,222
-6.85%
1,726,503
16.90%
Cost of revenue
888,214
1,527,984
1,692,736
Unusual Expense (Income)
NOPBT
81,248
80,238
33,767
NOPBT Margin
8.38%
4.99%
1.96%
Operating Taxes
(1,091)
1,246
(949)
Tax Rate
1.55%
NOPAT
82,339
78,992
34,716
Net income
82,280
-148.08%
(171,115)
-24.20%
(225,735)
66.35%
Dividends
Dividend yield
Proceeds from repurchase of equity
31
42,055
187,301
BB yield
0.00%
-15.27%
-8.25%
Debt
Debt current
94,543
35,507
5,182
Long-term debt
264,980
531,333
559,715
Deferred revenue
32,805
Other long-term liabilities
12,353
7,323
11,332
Net debt
303,886
439,107
282,214
Cash flow
Cash from operating activities
(87,415)
(97,287)
(130,631)
CAPEX
(4,988)
(59,289)
(63,477)
Cash from investing activities
219,819
(89,771)
(67,329)
Cash from financing activities
(202,627)
39,107
179,721
FCF
30,220
102,147
69,456
Balance
Cash
104,028
156,402
278,202
Long term investments
(48,391)
(28,669)
4,481
Excess cash
7,164
47,322
196,358
Stockholders' equity
489,170
411,449
516,231
Invested Capital
766,151
829,792
850,989
ROIC
10.32%
9.40%
4.01%
ROCE
10.41%
9.08%
3.20%
EV
Common stock shares outstanding
11,674
10,775
9,645
Price
73.75
188.54%
25.56
-89.15%
235.50
-16.78%
Market cap
860,932
212.59%
275,415
-87.88%
2,271,486
-11.57%
EV
1,164,818
714,522
2,553,700
EBITDA
124,684
142,868
84,910
EV/EBITDA
9.34
5.00
30.08
Interest
19,138
17,726
16,186
Interest/NOPBT
23.56%
22.09%
47.93%